Psychiatry Research
Volume 137, Issue 1 , Pages 29-36 , 15 November 2005

Predictors of psychiatrist-reported treatment-compliance problems among patients in routine U.S. psychiatric care

  • Michael T. Compton

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000, Atlanta, GA 30322, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 404 778 1486; fax: +1 404 616 3241.
    • ,
  • Bruce E. Rudisch

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000, Atlanta, GA 30322, USA
    • ,
  • Paul S. Weiss

      Affiliations

    • Department of Biostatistics, Rollins School of Public Health of Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA
    • ,
  • Joyce C. West

      Affiliations

    • Psychiatric Practice Research Network, American Psychiatric Institute for Research and Education, 1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209, USA
    • ,
  • Nadine J. Kaslow

      Affiliations

    • Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Suite 4000, Atlanta, GA 30322, USA

Received 10 April 2004 ,Revised 17 June 2005 ,Accepted 15 July 2005.

ReferencesReferences 

  1. Awad AG, Voruganti LN, Heslegrave RJ, Hogan TP. Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome. International Clinical Psychopharmacology. 1996;11(Suppl 2):55–59
  2. Bebbington PE. The content and context of compliance. International Clinical Psychopharmacology. 1995;9:41–50
  3. Bender B, Milgrom H, Rand C. Nonadherence in asthmatic patients: is there a solution to the problem?. Annals of Allergy, Asthma, and Immunology. 1997;79:177–185
  4. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. American Journal of Hospital Pharmacy. 1991;48:1978–1988
  5. Burgoyne RW, Acosta FX, Yamamoto J. Telephone prompting to increase attendance at a psychiatric outpatient clinic. American Journal of Psychiatry. 1983;140:345–347
  6. Campbell B, Staley D, Matas M. Who misses appointments? An empirical analysis. Canadian Journal of Psychiatry. 1991;36:223–225
  7. Centorrino F, Hernán MA, Drago-Ferrante G, Rendell M, Apicella A, Längar G, et al. Factors associated with noncompliance with psychiatric outpatient visits. Psychiatric Services. 2001;52:378–380
  8. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatric Services. 1998;49:196–201
  9. Dobscha SK, Delucchi K, Young ML. Adherence with referrals for outpatient follow-up from a VA psychiatric emergency room. Community Mental Health Journal. 1999;35:451–458
  10. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin. 1997;23:637–651
  11. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Davis JM, Lewis DA. Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry. 1995;152:856–861
  12. Krulee DA, Hales RE. Compliance with psychiatric referrals from a general hospital psychiatry outpatient clinic. General Hospital Psychiatry. 1988;10:339–345
  13. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry. 2002;63:892–909
  14. Linden M, Godemann F, Gaebel W, Kopke W, Muller P, Muller-Spahn F, et al. A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2 years. Schizophrenia Bulletin. 2001;27:585–596
  15. Marder SR, Mebane A, Chien CP, Winslade WJ, Swann E, Van Putten T. A comparison of patients who refuse and consent to neuroleptic treatment. American Journal of Psychiatry. 1983;140:470–472
  16. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. Journal of the American Medical Association. 2002;288:2868–2879
  17. Miner CR, Rosenthal RN, Hellerstein DJ, Muenz LR. Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders. Archives of General Psychiatry. 1997;54:706–712
  18. Pan PC, Tantam D. Clinical characteristics, health beliefs and compliance with maintenance treatment: a comparison between regular and irregular attenders at a depot clinic. Acta Psychiatrica Scandinavica. 1989;79:564–570
  19. Perkins DO. Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry. 2002;63:1121–1128
  20. Pincus HA, Zarin DA, Tanielian TL, Johnson JL, West JC, Pettit AR, et al. Psychiatric patients and treatments in 1997: findings from the American Psychiatric Practice Research Network. Archives of General Psychiatry. 1999;56:441–449
  21. Schaffer SD, Yoon SJL. Evidence-based methods to enhance medication adherence. Nurse Practitioner. 2001;26:44–54
  22. Shah BV, Barnwell BG, Bieler GS. 2001 SUDAAN User's Manual, Release 8.0: Software for the Statistical Analysis of Correlated Data. Research Triangle Park, NC: Research Triangle Institute; 2001;
  23. Sleath B, Wurst K, Lowery T. Drug information sources and antidepressant adherence. Community Mental Health Journal. 2003;39:359–368
  24. Smith CM, Yawn BP. Factors associated with appointment keeping in a family practice residency clinic. Journal of Family Practice. 1994;38:25–29
  25. Solomon P, Gordon B. Outpatient compliance of psychiatric emergency room patients by presenting problems. Psychiatric Quarterly. 1988;59:271–283
  26. Sparr LF, Moffitt MC, Ward MF. Missed psychiatric appointments: who returns and who stays away. American Journal of Psychiatry. 1993;150:801–805
  27. Thieda P, Beard S, Richter A, Kane J. An economic review of compliance with medication in the treatment of schizophrenia. Psychiatric Services. 2003;54:508–516
  28. Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L, et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care. 2002;40:630–639
  29. Velligan DI, Lam F, Ereshefsky L, Miller AL. Perspectives on medication adherence and atypical antipsychotic medications. Psychiatric Services. 2003;54:665–667
  30. Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, et al. Rating of Medication Influences (ROMI) scale in schizophrenia. Schizophrenia Bulletin. 1994;20:297–310
  31. Zarin DA, Pincus HA, West JC, McIntyre JS. Practice-based research in psychiatry. American Journal of Psychiatry. 1997;154:1199–1208

PII: S0165-1781(05)00212-X

doi: 10.1016/j.psychres.2005.07.009

Psychiatry Research
Volume 137, Issue 1 , Pages 29-36 , 15 November 2005

Article Tools